Europe Veterinary Regenerative Medicine Market Size & Outlook
Europe veterinary regenerative medicine market, 2018-2030 (US$M)
Related Markets
Europe veterinary regenerative medicine market highlights
- The Europe veterinary regenerative medicine market generated a revenue of USD 63.8 million in 2022.
- The market is expected to grow at a CAGR of 12% from 2023 to 2030.
- In terms of segment, stem cells was the largest revenue generating product in 2022.
- Other Products is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 63.8 million |
| Market revenue in 2030 | USD 157.8 million |
| Growth rate | 12% (CAGR from 2022 to 2030) |
| Largest segment | Stem cells |
| Fastest growing segment | Other Products |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stem cells, Other Products |
| Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
Other key industry trends
- In terms of revenue, Europe region accounted for 38.9% of the global veterinary regenerative medicine market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 65.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Regenerative Medicine Market Scope
Veterinary Regenerative Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe veterinary regenerative medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.35% in 2022. Horizon Databook has segmented the Europe veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
An aging pet population, rising pet ownership, ethical concerns, veterinary medicine advancements, continuous R&D, regulatory approvals, and pet owners' willingness to spend money on cutting-edge treatments for their beloved animals contribute to Europe's growing demand for veterinary regenerative medicines. With the advancement and increased accessibility of regenerative therapies, this trend is expected to boost market growth during the forecast period.
In addition, continuous research in regenerative medicine has resulted in the developing of effective and novel therapies for various animal conditions. These treatments are increasingly accessible, improving the ease of access for pet owners.
Reasons to subscribe to Europe veterinary regenerative medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe veterinary regenerative medicine market databook
-
Our clientele includes a mix of veterinary regenerative medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe veterinary regenerative medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Europe veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe veterinary regenerative medicine market size, by country, 2018-2030 (US$M)
Europe Veterinary Regenerative Medicine Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
